COMP <GO>
LINE vs MS // FORWARD P/E MULTIPLE
Lineage Inc. (NASDAQ) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: LINE 6
— MS 8
▲ FORWARD P/E MULTIPLE LEADER: MS
LAST: $36.00 (-0.61%) • MKT CAP: $8.25B
forward-pe
29.0x
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
forward-pe
16.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LINE VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LINE | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.10% | 41.00% | -8.90 | MS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.20% | 3.00% | -1.80 | MS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.8x | 31.0x | -16.20 | LINE | /valuation <GO> |
| Free Cash Flow Yield | 2.38% | -7.25% | +9.63 | LINE | /fcf-yield <GO> |
| Operating Margin | 3.40% | 24.60% | -21.20 | MS | /operating-margins <GO> |
| Net Profit Margin | -2.10% | 20.20% | -22.30 | MS | /net-margins <GO> |
| Revenue Growth (YoY) | 0.30% | 5.50% | -5.20 | MS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.51% | 2.21% | +4.30 | LINE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.61 | 0.46 | +0.15 | LINE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 7.00% | +0.20 | MS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.0 | 43.3 | +11.71 | LINE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.04 | +0.04 | LINE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 29.0x | 16.5x | +12.50 | MS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.25B | $298.41B | -$290.16B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LINE REV | MS REV | LINE GROSS % | MS GROSS % | LINE FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.36B | $0 | 32.1% | — | $196.0M | -$17.89B |
| FY 2024 | $5.34B | $0 | 33.0% | — | $12.0M | $1.36B |
| FY 2023 | $5.34B | $0 | 44.0% | — | $555.6M | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LINE // BETA 1.08
MS // BETA 1.04